"Aspirus is a non-profit, community-directed health system based in Wausau, Wisconsin. Its 7,700 employees are focused on improving the health and well-being of people throughout Wisconsin and Upper Michigan. Aspirus serves communities through four hospitals in Upper Michigan and four hospitals in Wisconsin, more than 50 clinics, home health and hospice care, pharmacies, critical care and air-medical transport, medical goods, nursing homes and a broad network of physicians. Aspirus was recognized by IBM Watson Health as a Top 15 Health System in its 2018 annual study identifying the top-performing health systems in the country."

During the past decade, Aspirus Medford Hospital conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 4 clinical trials were completed, i.e. on average, 9.3% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 4 clinical trials were completed. i.e. 15.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aspirus Medford Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 20 trials, followed by "SWOG Cancer Research Network" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "NRG Oncology" with 3 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aspirus Medford Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Aspirus Medford Hospital" are "Stage IV Lung Cancer AJCC v8" (6 trials), "Invasive Breast Carcinoma" (5 trials), "Stage IVA Lung Cancer AJCC v8" (5 trials), "Stage IVB Lung Cancer AJCC v8" (5 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (4 trials). Many other conditions were trialed in "Aspirus Medford Hospital" in a lesser frequency.

Most popular intervention types in "Aspirus Medford Hospital" are "Drug" (34 trials), "Other" (27 trials), "Biological" (20 trials), "Procedure" (20 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (15 trials), "Biospecimen Collection" (13 trials), "Computed Tomography" (13 trials), "Questionnaire Administration" (11 trials) and "Magnetic Resonance Imaging" (9 trials). Other intervention names were less common.

The vast majority of trials in "Aspirus Medford Hospital" are 41 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Aspirus Medford Hospital". undefined are not yet recruiting, 21 are recruiting, 20 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Aspirus Medford Hospital, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Aspirus Medford Hospital, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".